For 25 years, the Diabetes Research Center (DRC) of the Joslin Diabetes Center, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility (P&F) studies, has played a major role in fostering expansion in the scope and intensity of diabetes research at Joslin and Harvard Medical School. The DRC has provided essential infrastructure for basic, translational, and clinical research. During the last five year, Joslin DRC investigators have generated ground-breaking research aimed at understanding the pathogenesis of diabetes and its complications. These advances have been critically dependent upon the continually evolving cutting-edge technology and synergy of our DRC Cores. The current revised application builds upon these strengths and adds new and innovative components to the DRC. We propose to establish a Regional Resource Core at Boston University to enhance our capacity in computational biology that will allow us to move forward with next-generation sequencing and the other complexities of data management. The Boston University Joslin Regional Computational (BUJRC) Core will be accompanied by an expansion of the P&F Program, also at Boston University. For the Joslin-based Cores we propose a new DRC IPS Core. Clearly, IPS cells provide an extraordinary opportunity to study the pathogenesis of diabetes and its complications. Joslin is uniquely positioned to move forward because of its well-characterized patient populations and our close ties with the Harvard Stem Cell Institute. The new requirements for data generation have provided the opportunity to develop a new Advanced Genomics and Genetics Core, based on our previously distinct Genomics and Genetics Cores. The Advanced Microscopy Core, the Animal Physiology Core and the Flow Cytometry Core have all acquired sophisticated new equipment with substantial support from Joslin, and the new major award from State of Massachusetts resulting in a variety of new services. The P&F study program has been very successful in supporting young investigators and innovative research at Joslin and other Harvard institutions. The Enrichment Program continues to enhance the research environment for students, postdoctoral fellows and investigators by supporting a valuable array of academic exercises and visiting speakers.
The Joslin DRC, benefiting from its Cores, P&F Program and Enrichment Program has made extraordinary research advances for diabetes over the past 25 years and during the past grant period. The work has been highly translational and collaborative with important examples of basic findings being taken to the bedside to provide insights into pathophysiology of and new treatment strategies for diabetes.
|Pavkov, Meda E; Nelson, Robert G; Knowler, William C et al. (2015) Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int 87:812-9|
|Avadhani, Radhika; Fowler, Kristen; Barbato, Corinne et al. (2015) Glycemia and cognitive function in metabolic syndrome and coronary heart disease. Am J Med 128:46-55|
|Baskaran, Charumathi; Volkening, Lisa K; Diaz, Monica et al. (2015) A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes 16:263-70|
|Rasbach, Lisa; Jenkins, Carolyn; Laffel, Lori (2015) An integrative review of self-efficacy measurement instruments in youth with type 1 diabetes. Diabetes Educ 41:43-58|
|Castiglioni, Alessandra; Hettmer, Simone; Lynes, Matthew D et al. (2014) Isolation of progenitors that exhibit myogenic/osteogenic bipotency in vitro by fluorescence-activated cell sorting from human fetal muscle. Stem Cell Reports 2:92-106|
|Markowitz, Jessica T; Volkening, Lisa K; Laffel, Lori M B (2014) Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr 164:1384-9|
|Isganaitis, Elvira; Woo, Melissa; Ma, Huijuan et al. (2014) Developmental programming by maternal insulin resistance: hyperinsulinemia, glucose intolerance, and dysregulated lipid metabolism in male offspring of insulin-resistant mice. Diabetes 63:688-700|
|Teo, Adrian Kee Keong; Valdez, Ivan Achel; Dirice, Ercument et al. (2014) Comparable generation of activin-induced definitive endoderm via additive Wnt or BMP signaling in absence of serum. Stem Cell Reports 3:5-14|
|Lee, Hyung-Yul; Wei, Dan; Loeken, Mary R (2014) Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy. Diabetes Metab Res Rev 30:23-30|
|Sanders, Kaitlyn; Jung, Jin Hyuk; Loeken, Mary R (2014) Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancy. Birth Defects Res A Clin Mol Teratol 100:584-91|
Showing the most recent 10 out of 706 publications